The association between endometriosis and risk of endometrial cancer and breast cancer: a meta-analysis

Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differen...

Full description

Saved in:
Bibliographic Details
Published inBMC women's health Vol. 22; no. 1; pp. 455 - 21
Main Authors Ye, Jiatian, Peng, Hongling, Huang, Xia, Qi, Xiaorong
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 18.11.2022
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN1472-6874
1472-6874
DOI10.1186/s12905-022-02028-x

Cover

Loading…
Abstract Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias. Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)]. Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management.
AbstractList Abstract Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. Methods We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle–Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg’s and Egger’s tests to assess publication bias. Results Of the 1369 articles, we finally included 14 cohort studies and seven case–control studies. Data from large cohort and case–control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148–2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001–1.169)]. Conclusion Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management.
Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias. Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)]. Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management.
Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I.sup.2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias. Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)]. Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management.
Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis.PURPOSEEndometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis.We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias.METHODSWe searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias.Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)].RESULTSOf the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)].Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management.CONCLUSIONEndometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management.
Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. Methods We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I.sup.2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias. Results Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)]. Conclusion Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management. Keywords: Endometriosis, Endometrial cancer, Breast cancer, Risk, Meta-analysis
Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. Methods We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle–Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg’s and Egger’s tests to assess publication bias. Results Of the 1369 articles, we finally included 14 cohort studies and seven case–control studies. Data from large cohort and case–control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148–2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001–1.169)]. Conclusion Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management.
ArticleNumber 455
Audience Academic
Author Huang, Xia
Peng, Hongling
Qi, Xiaorong
Ye, Jiatian
Author_xml – sequence: 1
  givenname: Jiatian
  orcidid: 0000-0002-0419-3984
  surname: Ye
  fullname: Ye, Jiatian
– sequence: 2
  givenname: Hongling
  surname: Peng
  fullname: Peng, Hongling
– sequence: 3
  givenname: Xia
  surname: Huang
  fullname: Huang, Xia
– sequence: 4
  givenname: Xiaorong
  orcidid: 0000-0002-8382-9433
  surname: Qi
  fullname: Qi, Xiaorong
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36401252$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNURD_gD3BAkbhwSbGdxB8ckKqKj0qVuJSzNXbGWy9Zu9hZaP893uzSdiuEoijRzDNPMtZ7XB2EGLCqXlNySqnk7zNlivQNYazchMnm9ll1RDvBGi5Fd_Do_bA6znlJCBWyFy-qw5Z3hLKeHVWLq2usIedoPUw-htrg9Bsx1BiGuMIp-Zh9riEMdfL5Rx3dQwfG2kKwmOa2SQh52lU-1FAXBhoIMN4Vw8vquYMx46vd86T6_vnT1fnX5vLbl4vzs8vG9rydGiY4OMV7FEZ1TgzcIfatlEAscEGkUYpbDsKaDoziTlFhWyHLMtwqa1x7Ul1svUOEpb5JfgXpTkfwei7EtNCQJm9H1Nih4QNlA1rRuZbKwUjDeQeDowoELa6PW9fN2qxwsBimBOOedL8T_LVexF9acdG2pC2CdztBij_XmCe98tniOELAuM6aiVZSxZiSBX37BF3GdSqHN1OCM84pf6AWUBbwwcXyXbuR6jPByvkw2m9cp_-gyjXgytuSIedLfW_gzeNF7zf8G5MCsC1gU8w5obtHKNGbLOptFnXJop6zqG_LkHwyZP00h6z8jh__N_oHFUjjpQ
CitedBy_id crossref_primary_10_3390_biom13061003
crossref_primary_10_1136_ijgc_2023_005132
crossref_primary_10_1186_s43043_025_00219_8
crossref_primary_10_37349_etat_2023_00176
crossref_primary_10_1016_j_jeud_2023_100040
crossref_primary_10_1016_j_sciaf_2023_e01833
crossref_primary_10_5468_ogs_24242
crossref_primary_10_1016_j_jri_2025_104449
crossref_primary_10_3390_cancers15235667
crossref_primary_10_3390_curroncol31010032
crossref_primary_10_3390_futurepharmacol2040039
crossref_primary_10_31083_j_ceog5107169
crossref_primary_10_3390_cells14030156
crossref_primary_10_3390_biology13060397
crossref_primary_10_1002_hsr2_1274
crossref_primary_10_3390_clinpract14010001
crossref_primary_10_3390_biomedicines11030978
crossref_primary_10_21518_ms2024_497
crossref_primary_10_1016_j_ijgc_2025_101681
crossref_primary_10_1177_22840265241283520
crossref_primary_10_1038_s41598_024_58950_7
crossref_primary_10_1093_humrep_deae053
crossref_primary_10_1002_ijgo_15509
crossref_primary_10_1016_j_ejphar_2024_177031
crossref_primary_10_1016_j_heliyon_2024_e38130
crossref_primary_10_3390_medicina60081341
crossref_primary_10_3389_fonc_2023_1274340
crossref_primary_10_1158_1055_9965_EPI_23_1014
crossref_primary_10_3390_ijms25126775
crossref_primary_10_3390_biomedicines12122801
crossref_primary_10_1016_j_cjco_2023_11_003
crossref_primary_10_1002_wsbm_1624
crossref_primary_10_1007_s10549_023_07211_8
crossref_primary_10_1158_1078_0432_CCR_24_1205
crossref_primary_10_1186_s12940_023_01034_2
crossref_primary_10_1007_s12013_024_01420_8
crossref_primary_10_1016_j_isci_2024_109680
crossref_primary_10_3346_jkms_2024_39_e284
Cites_doi 10.7717/peerj.8135
10.1016/j.critrevonc.2018.12.009
10.1097/igc.0000000000000075
10.3390/ijms20153822
10.1093/humupd/dmaa045
10.1016/j.ygyno.2011.08.022
10.28991/HEF-2021-02-04-01
10.1097/01.ogx.0000529864.64356.76
10.1210/er.2012-1043
10.1016/j.mce.2013.07.026
10.3390/ijerph16183469
10.3390/ijms14035367
10.1016/j.critrevonc.2019.03.001
10.1200/jco.2013.48.9021
10.1016/j.jegh.2013.08.003
10.1016/j.ygyno.2016.07.095
10.28991/SciMedJ-2021-0302-8
10.1093/annonc/mdv484
10.1371/journal.pone.0194011
10.18632/oncotarget.19246
10.3389/frph.2021.661360
10.1038/bjc.2014.29
10.1186/s12885-015-1821-9
10.1007/s10549-014-3252-8
10.5301/jbm.2008.5555
10.1007/s00404-018-4968-1
10.1007/s00404-015-3809-8
10.9777/mcb.2013.10005
10.2174/1573406413666170424155452
10.1093/aje/kwq510
10.1016/j.freeradbiomed.2018.12.015
10.1080/13697137.2021.1948994
10.3390/cells10061381
10.3390/ijms22105196
10.1097/IGC.0000000000000384
10.1080/09513590.2020.1855634
10.1136/bmj.k2644
10.1016/j.ygyno.2021.01.019
10.1007/s10654-018-0474-9
10.1210/endrev/bnz001
10.1530/JME-15-0310
10.1007/s12325-020-01363-5
10.3760/cma.j.issn.0529-567x.2018.12.007
10.1186/s13048-019-0503-7
10.1097/AOG.0000000000001684
10.1089/jwh.2017.6432
10.3389/fgene.2021.631715
10.1016/j.bpobgyn.2018.06.001
10.3390/ijerph13111138
10.1097/IGC.0000000000000454
10.1016/j.gofs.2018.02.017
10.1016/j.cell.2021.04.041
10.17116/kurort20199606132
10.1002/ijc.31721
10.7150/jca.39626
10.1371/journal.pone.0143410
10.1186/s12905-019-0770-x
10.1177/1533034616666644
10.1038/s41572-018-0008-5
10.1007/s10552-014-0510-3
10.1158/1055-9965.EPI-13-0996
10.1007/s10552-017-0856-4
10.28991/SciMedJ-2021-0303-3
10.1136/bmj.327.7414.557
ContentType Journal Article
Copyright 2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2022
Copyright_xml – notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7R6
7RV
7X7
7XB
888
88E
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PMKZF
PPXIY
PQEST
PQGEN
PQQKQ
PQUKI
PSYQQ
QXPDG
7X8
5PM
DOA
DOI 10.1186/s12905-022-02028-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
GenderWatch
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
GenderWatch (Alumni Edition)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest Digital Collections
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Women's Studies
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest One Psychology
Diversity Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest One Sustainability
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Diversity Collection
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
GenderWatch (Alumni Edition)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Digital Collections
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
GenderWatch
ProQuest One Academic UKI Edition
ProQuest Women's & Gender Studies
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals (WRLC)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1472-6874
EndPage 21
ExternalDocumentID oai_doaj_org_article_e4eb6d12dec74f318db8b664adf19a71
PMC9673303
A727082158
36401252
10_1186_s12905_022_02028_x
Genre Meta-Analysis
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
04C
0R~
23N
2WC
53G
5VS
6J9
6PF
7R6
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACHQT
ACIHN
ACUHS
ADBBV
ADOJX
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BKEYQ
BMC
BMSDO
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
DU5
E3Z
EBD
EBLON
EBS
ECF
ECT
EIHBH
ESX
EX3
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
ICW
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PMKZF
PQQKQ
PROAC
PSQYO
PSYQQ
QXPDG
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGEN
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-276af965e7b94f7d6fee5388a0ca6708b996c6a7cb4ab96f917c3780126c9cbf3
IEDL.DBID M48
ISSN 1472-6874
IngestDate Wed Aug 27 01:25:51 EDT 2025
Thu Aug 21 18:39:54 EDT 2025
Tue Aug 05 10:14:13 EDT 2025
Sat Jul 26 03:31:33 EDT 2025
Tue Jun 17 21:31:18 EDT 2025
Tue Jun 10 20:54:29 EDT 2025
Thu Apr 03 07:03:31 EDT 2025
Tue Jul 01 00:26:24 EDT 2025
Thu Apr 24 23:02:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Endometriosis
Risk
Breast cancer
Endometrial cancer
Meta-analysis
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-276af965e7b94f7d6fee5388a0ca6708b996c6a7cb4ab96f917c3780126c9cbf3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Feature-1
content type line 23
ORCID 0000-0002-8382-9433
0000-0002-0419-3984
OpenAccessLink https://www.proquest.com/docview/2737626616?pq-origsite=%requestingapplication%
PMID 36401252
PQID 2737626616
PQPubID 42554
PageCount 21
ParticipantIDs doaj_primary_oai_doaj_org_article_e4eb6d12dec74f318db8b664adf19a71
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9673303
proquest_miscellaneous_2738192298
proquest_journals_2737626616
gale_infotracmisc_A727082158
gale_infotracacademiconefile_A727082158
pubmed_primary_36401252
crossref_primary_10_1186_s12905_022_02028_x
crossref_citationtrail_10_1186_s12905_022_02028_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-11-18
PublicationDateYYYYMMDD 2022-11-18
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-18
  day: 18
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC women's health
PublicationTitleAlternate BMC Womens Health
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References FE Lundberg (2028_CR32) 2019; 34
CL Williams (2028_CR25) 2018; 362
D Barca (2028_CR9) 2021; 2
L Del Pup (2028_CR65) 2019; 137
IJ Rowlands (2028_CR40) 2011; 123
L Saavalainen (2028_CR31) 2018; 143
PTK Saunders (2028_CR3) 2021; 184
J Bian (2028_CR53) 2017; 16
LA Brinton (2028_CR30) 2014; 23
2028_CR37
LV Shchegolikhina (2028_CR10) 2019; 96
2028_CR35
VC Kok (2028_CR29) 2015; 25
TL Rižner (2028_CR59) 2013; 381
A Nazmeen (2028_CR51) 2017; 13
JJ Kim (2028_CR55) 2013; 34
L Saraswat (2028_CR22) 2018; 73
G Schultes (2028_CR48) 1999; 149
L Huzell (2028_CR66) 2015; 149
HC Yu (2028_CR33) 2015; 25
2028_CR63
M Kvaskoff (2028_CR16) 2021; 27
V Dochez (2028_CR50) 2019; 12
SB Bhyan (2028_CR12) 2019; 7
JP Higgins (2028_CR28) 2003; 327
F Shen (2028_CR39) 2020; 11
F Guidozzi (2028_CR15) 2021; 24
2028_CR23
2028_CR20
AT Ali (2028_CR61) 2014; 24
C Fang (2028_CR52) 2017; 8
SK Bardaweel (2028_CR64) 2019; 19
A Maiorana (2028_CR49) 2007; 22
2028_CR19
2028_CR18
GA Wells (2028_CR27) 2014
J Li (2028_CR13) 2019; 299
S Gandini (2028_CR26) 2019; 134
ML Cote (2028_CR60) 2015; 26
LR Alvaro (2028_CR45) 2021; 3
O Olabode Ebenezer (2028_CR46) 2021; 3
2028_CR2
PG Moorman (2028_CR62) 2013; 31
2028_CR4
H Zhao (2028_CR58) 2016; 57
2028_CR7
N Colombo (2028_CR44) 2016; 27
2028_CR6
L Morales (2028_CR24) 2013; 3
B Borghese (2028_CR1) 2018; 46
HB Nichols (2028_CR38) 2011; 173
2028_CR11
H Kajiyama (2028_CR14) 2019; 133
Q Zhong (2028_CR47) 2021; 12
N Pedachenko (2028_CR57) 2021; 37
LM Mikhaleva (2028_CR8) 2020; 37
KT Zondervan (2028_CR5) 2018; 4
ES Surrey (2028_CR21) 2018; 27
2028_CR41
EM Poole (2028_CR36) 2017; 28
CC Yeh (2028_CR34) 2018; 13
F Anifantaki (2028_CR56) 2016; 293
HS Kim (2028_CR17) 2014; 110
MJ Worley (2028_CR54) 2013; 14
2028_CR43
2028_CR42
References_xml – volume: 7
  start-page: e8135
  year: 2019
  ident: 2028_CR12
  publication-title: PeerJ
  doi: 10.7717/peerj.8135
– volume: 134
  start-page: 72
  year: 2019
  ident: 2028_CR26
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2018.12.009
– volume: 24
  start-page: 384
  year: 2014
  ident: 2028_CR61
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/igc.0000000000000075
– ident: 2028_CR63
  doi: 10.3390/ijms20153822
– volume: 27
  start-page: 393
  year: 2021
  ident: 2028_CR16
  publication-title: Hum Reprod Update
  doi: 10.1093/humupd/dmaa045
– volume: 123
  start-page: 537
  year: 2011
  ident: 2028_CR40
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2011.08.022
– volume: 2
  start-page: 323
  year: 2021
  ident: 2028_CR9
  publication-title: J Human Earth Future
  doi: 10.28991/HEF-2021-02-04-01
– volume: 73
  start-page: 92
  year: 2018
  ident: 2028_CR22
  publication-title: Obstet Gynecol Survey
  doi: 10.1097/01.ogx.0000529864.64356.76
– volume: 34
  start-page: 130
  year: 2013
  ident: 2028_CR55
  publication-title: Endocr Rev
  doi: 10.1210/er.2012-1043
– volume: 381
  start-page: 124
  year: 2013
  ident: 2028_CR59
  publication-title: Mol Cellular Endocrinol
  doi: 10.1016/j.mce.2013.07.026
– ident: 2028_CR37
  doi: 10.3390/ijerph16183469
– volume: 14
  start-page: 5367
  year: 2013
  ident: 2028_CR54
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms14035367
– volume: 137
  start-page: 123
  year: 2019
  ident: 2028_CR65
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2019.03.001
– volume: 31
  start-page: 4188
  year: 2013
  ident: 2028_CR62
  publication-title: J Clin Oncol
  doi: 10.1200/jco.2013.48.9021
– volume: 3
  start-page: 205
  year: 2013
  ident: 2028_CR24
  publication-title: J Epidemiol Global Health
  doi: 10.1016/j.jegh.2013.08.003
– ident: 2028_CR20
  doi: 10.1016/j.ygyno.2016.07.095
– volume: 3
  start-page: 166
  year: 2021
  ident: 2028_CR45
  publication-title: SciMedicine J
  doi: 10.28991/SciMedJ-2021-0302-8
– volume: 27
  start-page: 16
  year: 2016
  ident: 2028_CR44
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdv484
– volume: 13
  start-page: e0194011
  year: 2018
  ident: 2028_CR34
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0194011
– volume: 8
  start-page: 63963
  year: 2017
  ident: 2028_CR52
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.19246
– ident: 2028_CR6
  doi: 10.3389/frph.2021.661360
– volume: 110
  start-page: 1878
  year: 2014
  ident: 2028_CR17
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2014.29
– ident: 2028_CR42
  doi: 10.1186/s12885-015-1821-9
– volume: 149
  start-page: 505
  year: 2015
  ident: 2028_CR66
  publication-title: Breast Cancer Res Treatment
  doi: 10.1007/s10549-014-3252-8
– volume: 22
  start-page: 200
  year: 2007
  ident: 2028_CR49
  publication-title: Int J Biol Markers
  doi: 10.5301/jbm.2008.5555
– volume: 299
  start-page: 35
  year: 2019
  ident: 2028_CR13
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-018-4968-1
– volume: 293
  start-page: 5
  year: 2016
  ident: 2028_CR56
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-015-3809-8
– ident: 2028_CR23
  doi: 10.9777/mcb.2013.10005
– volume-title: The Newcastle-Ottawa Scale (NOS) for Assessing The Quality of Nonrandomised Studies in Meta-analyses
  year: 2014
  ident: 2028_CR27
– volume: 13
  start-page: 796
  year: 2017
  ident: 2028_CR51
  publication-title: Med Chem
  doi: 10.2174/1573406413666170424155452
– volume: 173
  start-page: 1111
  year: 2011
  ident: 2028_CR38
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwq510
– volume: 133
  start-page: 186
  year: 2019
  ident: 2028_CR14
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2018.12.015
– volume: 24
  start-page: 587
  year: 2021
  ident: 2028_CR15
  publication-title: Climacteric
  doi: 10.1080/13697137.2021.1948994
– ident: 2028_CR2
  doi: 10.3390/cells10061381
– ident: 2028_CR7
  doi: 10.3390/ijms22105196
– volume: 25
  start-page: 447
  year: 2015
  ident: 2028_CR33
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/IGC.0000000000000384
– volume: 149
  start-page: 361
  year: 1999
  ident: 2028_CR48
  publication-title: Wien Med Wochenschr
– volume: 37
  start-page: 162
  year: 2021
  ident: 2028_CR57
  publication-title: Gynecol Endocrinol
  doi: 10.1080/09513590.2020.1855634
– volume: 362
  start-page: k2644
  year: 2018
  ident: 2028_CR25
  publication-title: BMJ
  doi: 10.1136/bmj.k2644
– ident: 2028_CR19
  doi: 10.1016/j.ygyno.2021.01.019
– volume: 34
  start-page: 499
  year: 2019
  ident: 2028_CR32
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-018-0474-9
– ident: 2028_CR11
  doi: 10.1210/endrev/bnz001
– volume: 57
  start-page: R19
  year: 2016
  ident: 2028_CR58
  publication-title: J Mol Endocrinol
  doi: 10.1530/JME-15-0310
– volume: 37
  start-page: 2580
  year: 2020
  ident: 2028_CR8
  publication-title: Adv Ther
  doi: 10.1007/s12325-020-01363-5
– ident: 2028_CR43
  doi: 10.3760/cma.j.issn.0529-567x.2018.12.007
– volume: 12
  start-page: 28
  year: 2019
  ident: 2028_CR50
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-019-0503-7
– ident: 2028_CR35
  doi: 10.1097/AOG.0000000000001684
– volume: 27
  start-page: 1114
  year: 2018
  ident: 2028_CR21
  publication-title: J Womens Health (Larchmt)
  doi: 10.1089/jwh.2017.6432
– volume: 12
  start-page: 631715
  year: 2021
  ident: 2028_CR47
  publication-title: Front Genet
  doi: 10.3389/fgene.2021.631715
– ident: 2028_CR4
  doi: 10.1016/j.bpobgyn.2018.06.001
– ident: 2028_CR18
  doi: 10.3390/ijerph13111138
– volume: 25
  start-page: 968
  year: 2015
  ident: 2028_CR29
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/IGC.0000000000000454
– volume: 46
  start-page: 156
  year: 2018
  ident: 2028_CR1
  publication-title: Gynecol Obstet Fertil Senol
  doi: 10.1016/j.gofs.2018.02.017
– volume: 184
  start-page: 2807
  year: 2021
  ident: 2028_CR3
  publication-title: Cell
  doi: 10.1016/j.cell.2021.04.041
– volume: 96
  start-page: 32
  year: 2019
  ident: 2028_CR10
  publication-title: Vopr Kurortol Fizioter Lech Fiz Kult
  doi: 10.17116/kurort20199606132
– volume: 143
  start-page: 2725
  year: 2018
  ident: 2028_CR31
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31721
– volume: 11
  start-page: 3186
  year: 2020
  ident: 2028_CR39
  publication-title: J Cancer
  doi: 10.7150/jca.39626
– ident: 2028_CR41
  doi: 10.1371/journal.pone.0143410
– volume: 19
  start-page: 72
  year: 2019
  ident: 2028_CR64
  publication-title: BMC Womens Health
  doi: 10.1186/s12905-019-0770-x
– volume: 16
  start-page: 435
  year: 2017
  ident: 2028_CR53
  publication-title: Technol Cancer Res Treat
  doi: 10.1177/1533034616666644
– volume: 4
  start-page: 9
  year: 2018
  ident: 2028_CR5
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-018-0008-5
– volume: 26
  start-page: 287
  year: 2015
  ident: 2028_CR60
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-014-0510-3
– volume: 23
  start-page: 584
  year: 2014
  ident: 2028_CR30
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-13-0996
– volume: 28
  start-page: 437
  year: 2017
  ident: 2028_CR36
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-017-0856-4
– volume: 3
  start-page: 219
  year: 2021
  ident: 2028_CR46
  publication-title: SciMedicine J
  doi: 10.28991/SciMedJ-2021-0303-3
– volume: 327
  start-page: 557
  year: 2003
  ident: 2028_CR28
  publication-title: BMJ
  doi: 10.1136/bmj.327.7414.557
SSID ssj0017857
Score 2.4796903
SecondaryResourceType review_article
Snippet Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer....
Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer....
Abstract Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 455
SubjectTerms Breast cancer
Breast Neoplasms - complications
Breast Neoplasms - epidemiology
Cancer therapies
Case studies
Case-Control Studies
Cohort analysis
Complications and side effects
Endometrial cancer
Endometrial Neoplasms - epidemiology
Endometriosis
Endometriosis - complications
Endometriosis - epidemiology
Endometrium
Estrogens
Female
Heterogeneity
Hormones
Humans
Infertility
Meta-analysis
Odds Ratio
Ovarian cancer
Ratios
Risk
Risk factors
Tumors
Womens health
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NixUxDC-yJ0HEb0dXqSB4kGHfdDpp620Vl0XQkwt7K_3UBZ2RfW9h_3yTTt_bNwh68fAuTWaYJmmT9CW_MvbapG4VA0Vug5PUkmNaL0JovYo-yow7oKcG589f4PRMfjofzveu-qKasBkeeBbcUZLJQ-xETEHJjBYYvfYA0sXcGVe6xwX6vG0yVf8_UHpQ2xYZDUdrOm2hTmSBPzpPul64oYLW_-eevOeUlgWTex7o5B67W0NHfjx_8n12K40P2J353I3P7UQP2TfUO3c3Mue1EIunMU4_6fqsaX2x5m6MnKrK-ZRvKPjyQEZwWcieytU3deQddxx5XOsqiMkjdnby8euH07ZeptCGAfpNKxS4bGBIyhuZVYScEm522q2CA7XSHhOfAE4FL503kDGNC70i_wXBBJ_7x-xgnMb0lHE5SI_SDyKjfjsdvI44AiquMirG5IZ1W9naUJHG6cKLH7ZkHBrsrA-L-rBFH_a6YW93z_yacTb-yv2eVLbjJIzsMoCWY6vl2H9ZTsPekMItrWT8vOBqQwJOkjCx7DGGdhggdYNu2OGCE1dgWJK3JmPrDrC2GBain8HoBxr2akemJ6mqbUzTVeEhPDph8BVPZgvbTakHzHzFIBqmFra3mPOSMl58L_jgBlSPkcmz_yGk5-y2oGVDhY_6kB1sLq_SCwzDNv5lWXG_AeuSMaQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1Na9RAdNB6EUSsn6lVRhA8SOgmmcxHL6UWSxH0ZGFvw3zWQk3qZgv9-X1vMpttEHrYy8xLmMn7fvs-CPmsQrXwDi231jAsyVGlrZ0rrfDWswgS0GKB889f_Oyc_Vi2yxxwG3Ja5UYmJkHte4cx8gNQs8C3oE340fW_EqdG4b-reYTGY_IEW5dhSpdYTg4XDp4Xm0IZyQ8GjLlgPXINP4wq3c6UUerZ_79kvqea5mmT9_TQ6QvyPBuQ9HjE-C55FLqX5NkYfaNjUdErcgHYp2b75WlOx6Kh8_1fHKLVD5cDNZ2nmFtO-7jdgZc7JIVV2raYtL7OK4fUUIAxpcmtTF6T89Pvv0_OyjxSoXQtb9ZlLbiJirdBWMWi8DyGACJPmoUzXCykBffHcSOcZcYqHsGZc41ALcadcjY2b8hO13fhHaGsZdbHytURsFxJZ6WHFS78InLOVCxItfm22uV-4zj24konv0NyPeJDAz50woe-LcjX6ZnrsdvGg9DfEGUTJHbKTgv96kJnxtOBBct9VfvgBIsgwbyVFg5o4OzKiKogXxDhGvkZjudMLkuAS2JnLH0MBh6YSVUrC7I_gwQ-dPPtDcnoLAcGvaXagnyatvFJzG3rQn-TYLArXa3gFW9HCpuu1HDwf-u2LoiY0d7szvOd7vJP6hKuuGjAPtl7-FjvydMaGQITG-U-2VmvbsIHMLPW9mPipTvETSfz
  priority: 102
  providerName: ProQuest
Title The association between endometriosis and risk of endometrial cancer and breast cancer: a meta-analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/36401252
https://www.proquest.com/docview/2737626616
https://www.proquest.com/docview/2738192298
https://pubmed.ncbi.nlm.nih.gov/PMC9673303
https://doaj.org/article/e4eb6d12dec74f318db8b664adf19a71
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1daxQxMNT2RRDx29V6RBB8kNXbbDbJCiI9aSlCixQPDl9CPmuh7rZ3V6j_3pns3l0Xi_hw95CZzSU7M5mZ3HwQ8qYOxdg7tNwqwzElp84tcy630lvPI5yAFhOcj47F4ZR_nVWzLbJqd9S_wMWtrh32k5rOz99fX_7-DAL_KQm8Eh8WeJeCecYMPnhbBDblDmgmiYJ6xDf_KkiVKn8WXLJcKMlXSTS3zjFQVKme_9-n9g21NQypvKGjDh6Q-71xSfc6bnhItkLziNzrbuZol3D0mJwCZ1CzoQrtQ7VoaHz7CxtstYuzBTWNpxh3Ttu4gcDkDtlknsAWA9qX_chHaijgmNz0ZU6ekOnB_vcvh3nfbiF3lSiXOZPCxFpUQdqaR-lFDAGOQ2XGzgg5VhZcIyeMdJYbW4sIjp4rJWo44WpnY_mUbDdtE54TyitufSwci8ABhXJWeRgR0o-jELyOGSlW71a7vhY5tsQ418knUUJ39NBAD53ooa8z8m79zEVXieOf2BMk2RoTq2ingXZ-qnuh1IEHK3zBfHCSRzjdvFUWFmhg7bWRRUbeIsE1ch8sz5k-ZQE2iVWz9B4Yf2BCFZXKyO4AE2TUDcErltErFtdgOIImAvtIZOT1GoxPYtxbE9qrhIMV61gNUzzrOGy9pVKAb8wqlhE54L3BnoeQ5uxnqiBeC1mC7fLiP373JbnLUCow8lHtku3l_Cq8AjtsaUfkjpzJEdmZ7B9_Oxml24xREjj4Ppn8-AMORzPK
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3batRAdKjbBwUR70arjqD4IKGbyWQmEURabdnadhFpoW_TudaCJnWzxfpTfqPn5LLbIPStD3mZORlmcu6TcyHkdeGTsbNouWWaY0pOERtmbWykM44HkIAGE5z3p2JyyL8cZUcr5G-fC4Nhlb1MbAS1qyzeka-DmgW-BW0iPp79irFrFP5d7VtotGSx6__8Bpet_rDzGfD7hrHtrYNPk7jrKhDbTKTzmEmhQyEyL03Bg3QieA9cn-ux1UKOcwMegBVaWsO1KUQAf8amEgW5sIU1IYV1b5BVnoIrMyKrm1vTr98W_y1knsk-NScX6zXe8mAGNIMH77EuBuqv6RLwvy64pAyHgZqXNN_2XXKnM1npRktj98iKL--T2-19H23TmB6QE6A3qpe4pl0AGPWlq35i266qPq2pLh3FaHZaheUMLG6R-GbNtMEw-Xk38p5qCjA61l3xlIfk8Fo-9yMyKqvSPyGUZ9y4kFgWgK6S3JrcwYiQbhyE4EWISNJ_W2W7CufYaOOHajydXKgWHwrwoRp8qIuIvFu8c9bW97gSehNRtoDE2tzNQDU7UR2rK8-9ES5hzlvJA8hMZ3IDG9Sw90LLJCJvEeEKJQhsz-ouEQIOibW41AaYlGCYJVkekbUBJHC-HU73JKM6yVOrJZ9E5NViGt_EaLrSV-cNDNbBYwUs8bilsMWRUgEeN8tYROSA9gZnHs6Up9-buuSFkClYRE-v3tZLcnNysL-n9namu8_ILYbMgWGV-RoZzWfn_jkYeXPzouMsSo6vm5n_AZ4iZrI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+between+endometriosis+and+risk+of+endometrial+cancer+and+breast+cancer%3A+a+meta-analysis&rft.jtitle=BMC+women%27s+health&rft.au=Ye%2C+Jiatian&rft.au=Peng%2C+Hongling&rft.au=Huang%2C+Xia&rft.au=Qi%2C+Xiaorong&rft.date=2022-11-18&rft.issn=1472-6874&rft.eissn=1472-6874&rft.volume=22&rft.issue=1&rft.spage=455&rft_id=info:doi/10.1186%2Fs12905-022-02028-x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6874&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6874&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6874&client=summon